Rivalry, strategic groups and firm profitability
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071012740 | ||
| 003 | MAP | ||
| 005 | 20080418113318.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 930416e19930101gbr|||| | |00010|eng d | ||
| 040 | $aMAP$bspa | ||
| 084 | $a922.111 | ||
| 100 | 1 | $0MAPA20080022358$aCool, Karel | |
| 245 | 1 | 0 | $aRivalry, strategic groups and firm profitability$cKarel Cool and Ingemar Dierickx |
| 520 | $aAn analysis of the U.S. pharmaceutical industry during the period 1963-82 finds that a substancial decline in industry profitability is not explained by changes in the number and size distribution of firms, in segment interdependence and in strategic distance. In contrast, declining industry profitability is strongly associated with increasing rivalry. This increasing rivalry is associated with changes in strategic group structure and a concomitant shift from within group rivalry to between group rivalry | ||
| 650 | 1 | 1 | $0MAPA20080606633$aIndustria farmacéutica |
| 650 | 1 | 1 | $0MAPA20080606091$aEstrategia empresarial |
| 650 | 1 | 1 | $0MAPA20080557591$aCompetencia |
| 650 | 1 | 1 | $0MAPA20080563974$aRentabilidad |
| 650 | 1 | 1 | $0MAPA20080594688$aAnálisis estratégico |
| 700 | 1 | $0MAPA20080190057$aDierickx, Ingemar | |
| 740 | 0 | $aStrategic management journal | |
| 773 | 0 | $wMAP20077100307$tStrategic management journal$dChichester [etc.]$gnº 1, January 1993 ; p. 47-59 |